Global NGS-based RNA-seq Market Research Report 2025(Status and Outlook)

March 2025 | 214 pages | ID: GE5FF63C5761EN
Bosson Research

Abstracts

Report Overview

Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.

This report provides a deep insight into the global NGS-based RNA-seq market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global NGS-based RNA-seq Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the NGS-based RNA-seq market in any manner.

Global NGS-based RNA-seq Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Illumina

Thermo Fisher Scientific

Pacific Biosciences Of California

Qaigen

F. Hoffmann-La Roche

Agilent Technologies

Oxford Nanopore Technologies

Perkinelmer

Eurofins Scientific

Gatc Biotech

Macrogen

Market Segmentation (by Type)

High-Throughput Sequencing

Third-Generation Sequencing Technology

Market Segmentation (by Application)

Hospitals and Clinics

Biopharma Companies

Government Agencies

Academic and Research Organizations

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the NGS-based RNA-seq Market
• Overview of the regional outlook of the NGS-based RNA-seq Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NGS-based RNA-seq Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of NGS-based RNA-seq
1.2 Key Market Segments
1.2.1 NGS-based RNA-seq Segment by Type
1.2.2 NGS-based RNA-seq Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global NGS-based RNA-seq Market Overview
2.1 Global Market Overview
2.1.1 Global NGS-based RNA-seq Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global NGS-based RNA-seq Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global NGS-based RNA-seq Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global NGS-based RNA-seq Product Life Cycle
3.3 Global NGS-based RNA-seq Sales by Manufacturers (2020-2025)
3.4 Global NGS-based RNA-seq Revenue Market Share by Manufacturers (2020-2025)
3.5 NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global NGS-based RNA-seq Average Price by Manufacturers (2020-2025)
3.7 Manufacturers NGS-based RNA-seq Manufacturing Sites, Area Served, Product Type
3.8 NGS-based RNA-seq Market Competitive Situation and Trends
3.8.1 NGS-based RNA-seq Market Concentration Rate
3.8.2 Global 5 and 10 Largest NGS-based RNA-seq Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NGS-based RNA-seq Industry Chain Analysis
4.1 NGS-based RNA-seq Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of NGS-based RNA-seq Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global NGS-based RNA-seq Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to NGS-based RNA-seq Market
5.7 ESG Ratings of Leading Companies
6 Global NGS-based RNA-seq Market Sales by Region
6.1 Global NGS-based RNA-seq Sales by Region
6.1.1 Global NGS-based RNA-seq Sales by Region
6.1.2 Global NGS-based RNA-seq Sales Market Share by Region
6.2 Global NGS-based RNA-seq Market Size by Region
6.2.1 Global NGS-based RNA-seq Market Size by Region
6.2.2 Global NGS-based RNA-seq Market Size Market Share by Region
7 North America Market Overview
7.1 North America NGS-based RNA-seq Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America NGS-based RNA-seq Market Size by Type
7.3 North America NGS-based RNA-seq Market Size by Application
8 Europe Market Overview
8.1 Europe NGS-based RNA-seq Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe NGS-based RNA-seq Market Size by Type
8.3 Europe NGS-based RNA-seq Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific NGS-based RNA-seq Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific NGS-based RNA-seq Market Size by Type
9.3 Asia-Pacific NGS-based RNA-seq Market Size by Application
10 South America Market Overview
10.1 South America NGS-based RNA-seq Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America NGS-based RNA-seq Market Size by Type
10.3 South America NGS-based RNA-seq Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa NGS-based RNA-seq Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa NGS-based RNA-seq Market Size by Type
11.3 Middle East and Africa NGS-based RNA-seq Market Size by Application
12 NGS-based RNA-seq Market Production by Region
12.1 Global Production of NGS-based RNA-seq by Region(2020-2025)
12.2 Global NGS-based RNA-seq Revenue Market Share by Region (2020-2025)
12.3 Global NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America NGS-based RNA-seq Production
12.4.1 North America NGS-based RNA-seq Production Growth Rate (2020-2025)
12.4.2 North America NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe NGS-based RNA-seq Production
12.5.1 Europe NGS-based RNA-seq Production Growth Rate (2020-2025)
12.5.2 Europe NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan NGS-based RNA-seq Production (2020-2025)
12.6.1 Japan NGS-based RNA-seq Production Growth Rate (2020-2025)
12.6.2 Japan NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China NGS-based RNA-seq Production (2020-2025)
12.7.1 China NGS-based RNA-seq Production Growth Rate (2020-2025)
12.7.2 China NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
13 NGS-based RNA-seq Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global NGS-based RNA-seq Sales Market Share by Type (2020-2033)
13.3 Global NGS-based RNA-seq Market Size Market Share by Type (2020-2033)
13.4 Global NGS-based RNA-seq Price by Type (2020-2033)
14 NGS-based RNA-seq Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global NGS-based RNA-seq Market Sales by Application (2020-2033)
14.3 Global NGS-based RNA-seq Market Size (M USD) by Application (2020-2033)
14.4 Global NGS-based RNA-seq Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Illumina
15.1.1 Illumina Basic Information
15.1.2 Illumina NGS-based RNA-seq Product Overview
15.1.3 Illumina NGS-based RNA-seq Product Market Performance
15.1.4 Illumina Business Overview
15.1.5 Illumina SWOT Analysis
15.1.6 Illumina Recent Developments
15.2 Thermo Fisher Scientific
15.2.1 Thermo Fisher Scientific Basic Information
15.2.2 Thermo Fisher Scientific NGS-based RNA-seq Product Overview
15.2.3 Thermo Fisher Scientific NGS-based RNA-seq Product Market Performance
15.2.4 Thermo Fisher Scientific Business Overview
15.2.5 Thermo Fisher Scientific SWOT Analysis
15.2.6 Thermo Fisher Scientific Recent Developments
15.3 Pacific Biosciences Of California
15.3.1 Pacific Biosciences Of California Basic Information
15.3.2 Pacific Biosciences Of California NGS-based RNA-seq Product Overview
15.3.3 Pacific Biosciences Of California NGS-based RNA-seq Product Market Performance
15.3.4 Pacific Biosciences Of California Business Overview
15.3.5 Pacific Biosciences Of California SWOT Analysis
15.3.6 Pacific Biosciences Of California Recent Developments
15.4 Qaigen
15.4.1 Qaigen Basic Information
15.4.2 Qaigen NGS-based RNA-seq Product Overview
15.4.3 Qaigen NGS-based RNA-seq Product Market Performance
15.4.4 Qaigen Business Overview
15.4.5 Qaigen Recent Developments
15.5 F. Hoffmann-La Roche
15.5.1 F. Hoffmann-La Roche Basic Information
15.5.2 F. Hoffmann-La Roche NGS-based RNA-seq Product Overview
15.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Product Market Performance
15.5.4 F. Hoffmann-La Roche Business Overview
15.5.5 F. Hoffmann-La Roche Recent Developments
15.6 Agilent Technologies
15.6.1 Agilent Technologies Basic Information
15.6.2 Agilent Technologies NGS-based RNA-seq Product Overview
15.6.3 Agilent Technologies NGS-based RNA-seq Product Market Performance
15.6.4 Agilent Technologies Business Overview
15.6.5 Agilent Technologies Recent Developments
15.7 Oxford Nanopore Technologies
15.7.1 Oxford Nanopore Technologies Basic Information
15.7.2 Oxford Nanopore Technologies NGS-based RNA-seq Product Overview
15.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Product Market Performance
15.7.4 Oxford Nanopore Technologies Business Overview
15.7.5 Oxford Nanopore Technologies Recent Developments
15.8 Perkinelmer
15.8.1 Perkinelmer Basic Information
15.8.2 Perkinelmer NGS-based RNA-seq Product Overview
15.8.3 Perkinelmer NGS-based RNA-seq Product Market Performance
15.8.4 Perkinelmer Business Overview
15.8.5 Perkinelmer Recent Developments
15.9 Eurofins Scientific
15.9.1 Eurofins Scientific Basic Information
15.9.2 Eurofins Scientific NGS-based RNA-seq Product Overview
15.9.3 Eurofins Scientific NGS-based RNA-seq Product Market Performance
15.9.4 Eurofins Scientific Business Overview
15.9.5 Eurofins Scientific Recent Developments
15.10 Gatc Biotech
15.10.1 Gatc Biotech Basic Information
15.10.2 Gatc Biotech NGS-based RNA-seq Product Overview
15.10.3 Gatc Biotech NGS-based RNA-seq Product Market Performance
15.10.4 Gatc Biotech Business Overview
15.10.5 Gatc Biotech Recent Developments
15.11 Macrogen
15.11.1 Macrogen Basic Information
15.11.2 Macrogen NGS-based RNA-seq Product Overview
15.11.3 Macrogen NGS-based RNA-seq Product Market Performance
15.11.4 Macrogen Business Overview
15.11.5 Macrogen Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. NGS-based RNA-seq Market Size Comparison by Region (M USD)
Table 5. Global NGS-based RNA-seq Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global NGS-based RNA-seq Sales Market Share by Manufacturers (2020-2025)
Table 7. Global NGS-based RNA-seq Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global NGS-based RNA-seq Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-seq as of 2024)
Table 10. Global Market NGS-based RNA-seq Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers NGS-based RNA-seq Manufacturing Sites and Area Served
Table 12. Manufacturers NGS-based RNA-seq Product Type
Table 13. Global NGS-based RNA-seq Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. NGS-based RNA-seq Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global NGS-based RNA-seq Sales by Region (2020-2025) & (K Units)
Table 25. Global NGS-based RNA-seq Sales Market Share by Region (2020-2025)
Table 26. Global NGS-based RNA-seq Market Size by Region (2020-2025) & (M USD)
Table 27. Global NGS-based RNA-seq Market Size Market Share by Region (2020-2025)
Table 28. North America NGS-based RNA-seq Market Size by Country (2020-2033) & (M USD)
Table 29. North America NGS-based RNA-seq Sales by Country (2020-2033) & (K Units)
Table 30. North America NGS-based RNA-seq Sales by Type (K Units)
Table 31. North America NGS-based RNA-seq Market Size by Type (M USD)
Table 32. North America NGS-based RNA-seq Sales (K Units) by Type (2020-2033)
Table 33. North America NGS-based RNA-seq Market Size (M USD) by Type (2020-2033)
Table 34. North America NGS-based RNA-seq Sales by Application (K Units)
Table 35. North America NGS-based RNA-seq Market Size by Application (M USD)
Table 36. North America NGS-based RNA-seq Sales (K Units) by Application (2020-2033)
Table 37. North America NGS-based RNA-seq Market Size (M USD) by Application (2020-2033)
Table 38. Europe NGS-based RNA-seq Market Size by Country (2020-2033) & (M USD)
Table 39. Europe NGS-based RNA-seq Sales by Country (2020-2033) & (K Units)
Table 40. Europe NGS-based RNA-seq Sales by Type (K Units)
Table 41. Europe NGS-based RNA-seq Market Size by Type (M USD)
Table 42. Europe NGS-based RNA-seq Sales (K Units) by Type (2020-2033)
Table 43. Europe NGS-based RNA-seq Market Size (M USD) by Type (2020-2033)
Table 44. Europe NGS-based RNA-seq Sales by Application (K Units)
Table 45. Europe NGS-based RNA-seq Market Size by Application (M USD)
Table 46. Europe NGS-based RNA-seq Sales (K Units) by Application (2020-2033)
Table 47. Europe NGS-based RNA-seq Market Size (M USD) by Application (2020-2033)
Table 48. Asia-Pacific NGS-based RNA-seq Market Size by Country (2020-2025) & (M USD)
Table 49. Asia-Pacific NGS-based RNA-seq Sales by Country (2020-2025) & (K Units)
Table 50. Asia-Pacific NGS-based RNA-seq Sales by Type (K Units)
Table 51. Asia-Pacific NGS-based RNA-seq Market Size by Type (M USD)
Table 52. Asia-Pacific NGS-based RNA-seq Sales (K Units) by Type (2020-2033)
Table 53. Asia-Pacific NGS-based RNA-seq Market Size (M USD) by Type (2020-2025)
Table 54. Asia-Pacific NGS-based RNA-seq Sales by Application (K Units)
Table 55. Asia-Pacific NGS-based RNA-seq Market Size by Application (M USD)
Table 56. Asia-Pacific NGS-based RNA-seq Sales (K Units) by Application (2020-2033)
Table 57. Asia-Pacific NGS-based RNA-seq Market Size (M USD) by Application (2020-2025)
Table 58. South America NGS-based RNA-seq Market Size by Country (2020-2033) & (M USD)
Table 59. South America NGS-based RNA-seq Sales by Country (2020-2033) & (K Units)
Table 60. South America NGS-based RNA-seq Sales by Type (K Units)
Table 61. South America NGS-based RNA-seq Market Size by Type (M USD)
Table 62. South America NGS-based RNA-seq Sales (K Units) by Type (2020-2033)
Table 63. South America NGS-based RNA-seq Market Size (M USD) by Type (2020-2033)
Table 64. South America NGS-based RNA-seq Sales by Application (K Units)
Table 65. South America NGS-based RNA-seq Market Size by Application (M USD)
Table 66. South America NGS-based RNA-seq Sales (K Units) by Application (2020-2033)
Table 67. South America NGS-based RNA-seq Market Size (M USD) by Application (2020-2033)
Table 68. Middle East and Africa NGS-based RNA-seq Market Size by Country (2020-2033) & (M USD)
Table 69. Middle East and Africa NGS-based RNA-seq Sales by Country (2020-2033) & (K Units)
Table 70. Middle East and Africa NGS-based RNA-seq Sales by Type (K Units)
Table 71. Middle East and Africa NGS-based RNA-seq Market Size by Type (M USD)
Table 72. Middle East and Africa NGS-based RNA-seq Sales (K Units) by Type (2020-2033)
Table 73. Middle East and Africa NGS-based RNA-seq Market Size (M USD) by Type (2020-2033)
Table 74. Middle East and Africa NGS-based RNA-seq Sales by Application (K Units)
Table 75. Middle East and Africa NGS-based RNA-seq Market Size by Application (M USD)
Table 76. Middle East and Africa NGS-based RNA-seq Sales (K Units) by Application (2020-2033)
Table 77. Middle East and Africa NGS-based RNA-seq Market Size (M USD) by Application (2020-2033)
Table 78. Global NGS-based RNA-seq Production (K Units) by Region(2020-2025)
Table 79. Global NGS-based RNA-seq Revenue (US$ Million) by Region (2020-2025)
Table 80. Global NGS-based RNA-seq Revenue Market Share by Region (2020-2025)
Table 81. Global NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. North America NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Europe NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Japan NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. China NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Global NGS-based RNA-seq Sales by Type (K Units)
Table 87. Global NGS-based RNA-seq Market Size by Type (M USD)
Table 88. Global NGS-based RNA-seq Sales (K Units) by Type (2020-2033)
Table 89. Global NGS-based RNA-seq Sales Market Share by Type (2020-2033)
Table 90. Global NGS-based RNA-seq Market Size (M USD) by Type (2020-2033)
Table 91. Global NGS-based RNA-seq Market Size Share by Type (2020-2033)
Table 92. Global NGS-based RNA-seq Sales (K Units) by Application
Table 93. Global NGS-based RNA-seq Market Size by Application(M USD)
Table 94. Global NGS-based RNA-seq Sales by Application (2020-2033) & (K Units)
Table 95. Global NGS-based RNA-seq Sales Market Share by Application (2020-2033)
Table 96. Global NGS-based RNA-seq Market Size by Application (2020-2033) & (M USD)
Table 97. Global NGS-based RNA-seq Market Share by Application (2020-2033)
Table 98. Global NGS-based RNA-seq Sales Growth Rate by Application (2020-2033)
Table 99. Illumina Basic Information
Table 100. Illumina NGS-based RNA-seq Product Overview
Table 101. Illumina NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Illumina Business Overview
Table 103. Illumina SWOT Analysis
Table 104. Illumina Recent Developments
Table 105. Thermo Fisher Scientific Basic Information
Table 106. Thermo Fisher Scientific NGS-based RNA-seq Product Overview
Table 107. Thermo Fisher Scientific NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Thermo Fisher Scientific Business Overview
Table 109. Thermo Fisher Scientific SWOT Analysis
Table 110. Thermo Fisher Scientific Recent Developments
Table 111. Pacific Biosciences Of California Basic Information
Table 112. Pacific Biosciences Of California NGS-based RNA-seq Product Overview
Table 113. Pacific Biosciences Of California NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. Pacific Biosciences Of California Business Overview
Table 115. Pacific Biosciences Of California SWOT Analysis
Table 116. Pacific Biosciences Of California Recent Developments
Table 117. Qaigen Basic Information
Table 118. Qaigen NGS-based RNA-seq Product Overview
Table 119. Qaigen NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Qaigen Business Overview
Table 121. Qaigen Recent Developments
Table 122. F. Hoffmann-La Roche Basic Information
Table 123. F. Hoffmann-La Roche NGS-based RNA-seq Product Overview
Table 124. F. Hoffmann-La Roche NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. F. Hoffmann-La Roche Business Overview
Table 126. F. Hoffmann-La Roche Recent Developments
Table 127. Agilent Technologies Basic Information
Table 128. Agilent Technologies NGS-based RNA-seq Product Overview
Table 129. Agilent Technologies NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Agilent Technologies Business Overview
Table 131. Agilent Technologies Recent Developments
Table 132. Oxford Nanopore Technologies Basic Information
Table 133. Oxford Nanopore Technologies NGS-based RNA-seq Product Overview
Table 134. Oxford Nanopore Technologies NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Oxford Nanopore Technologies Business Overview
Table 136. Oxford Nanopore Technologies Recent Developments
Table 137. Perkinelmer Basic Information
Table 138. Perkinelmer NGS-based RNA-seq Product Overview
Table 139. Perkinelmer NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Perkinelmer Business Overview
Table 141. Perkinelmer Recent Developments
Table 142. Eurofins Scientific Basic Information
Table 143. Eurofins Scientific NGS-based RNA-seq Product Overview
Table 144. Eurofins Scientific NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Eurofins Scientific Business Overview
Table 146. Eurofins Scientific Recent Developments
Table 147. Gatc Biotech Basic Information
Table 148. Gatc Biotech NGS-based RNA-seq Product Overview
Table 149. Gatc Biotech NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 150. Gatc Biotech Business Overview
Table 151. Gatc Biotech Recent Developments
Table 152. Macrogen Basic Information
Table 153. Macrogen NGS-based RNA-seq Product Overview
Table 154. Macrogen NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 155. Macrogen Business Overview
Table 156. Macrogen Recent Developments
List of Figures
Figure 1. Product Picture of NGS-based RNA-seq
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global NGS-based RNA-seq Market Size (M USD), 2024-2033
Figure 5. Global NGS-based RNA-seq Market Size (M USD) (2020-2033)
Figure 6. Global NGS-based RNA-seq Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. NGS-based RNA-seq Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global NGS-based RNA-seq Product Life Cycle
Figure 13. NGS-based RNA-seq Sales Share by Manufacturers in 2024
Figure 14. Global NGS-based RNA-seq Revenue Share by Manufacturers in 2024
Figure 15. NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market NGS-based RNA-seq Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by NGS-based RNA-seq Revenue in 2024
Figure 18. Industry Chain Map of NGS-based RNA-seq
Figure 19. Global NGS-based RNA-seq Market PEST Analysis
Figure 20. Global NGS-based RNA-seq Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Global NGS-based RNA-seq Sales Market Share by Region (2020-2025)
Figure 26. Global NGS-based RNA-seq Market Size Market Share by Region (2020-2025)
Figure 27. North American Market Snapshot
Figure 28. North America NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 29. North America NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 30. North America NGS-based RNA-seq Market Size (M USD) by Country
Figure 31. USA NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 32. USA NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 33. Canada NGS-based RNA-seq Sales (K Units) and Growth Rate (2020-2033)
Figure 34. Canada NGS-based RNA-seq Market Size (M USD) and Growth Rate (2020-2033)
Figure 35. Mexico NGS-based RNA-seq Sales (Units) and Growth Rate (2020-2033)
Figure 36. Mexico NGS-based RNA-seq Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. North America NGS-based RNA-seq Market Size (M USD)by Type
Figure 38. North America NGS-based RNA-seq Market Size (M USD) by Application
Figure 39. Europe Market Snapshot
Figure 40. Europe NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 41. Europe NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 42. Europe NGS-based RNA-seq Market Size (M USD) by Country
Figure 43. Germany NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 44. Germany NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 45. France NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. France NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. U.K. NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. U.K. NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 49. Italy NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. Italy NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 51. Spain NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Spain NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Europe NGS-based RNA-seq Market Size (M USD) by Type
Figure 54. Europe NGS-based RNA-seq Market Size (M USD) by Application
Figure 55. Asia-Pacific Market Snapshot
Figure 56. Asia-Pacific NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 57. Asia-Pacific NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Asia-Pacific NGS-based RNA-seq Market Size (M USD) by Country
Figure 59. China NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. China NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Japan NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Japan NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. South Korea NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. South Korea NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. India NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. India NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. Southeast Asia NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. Southeast Asia NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Asia-Pacific NGS-based RNA-seq Market Size (M USD) by Type
Figure 70. Asia-Pacific NGS-based RNA-seq Market Size (M USD) by Application
Figure 71. South America Market Snapshot
Figure 72. South America NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 73. South America NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 74. South America NGS-based RNA-seq Market Size (M USD) by Country
Figure 75. Brazil NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 76. Brazil NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 77. Argentina NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Argentina NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Columbia NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Columbia NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. South America NGS-based RNA-seq Market Size (M USD) by Type
Figure 82. South America NGS-based RNA-seq Market Size (M USD) by Application
Figure 83. Middle East and Africa Market Snapshot
Figure 84. Middle East and Africa NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 85. Middle East and Africa NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 86. Middle East and Africa NGS-based RNA-seq Market Size (M USD) by Country
Figure 87. Saudi Arabia NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 88. Saudi Arabia NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 89. UAE NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. UAE NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. Egypt NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. Egypt NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Nigeria NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Nigeria NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. South Africa NGS-based RNA-seq Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. South Africa NGS-based RNA-seq Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. Middle East and Africa NGS-based RNA-seq Market Size (M USD) by Type
Figure 98. Middle East and Africa NGS-based RNA-seq Market Size (M USD) by Application
Figure 99. Global NGS-based RNA-seq Production Market Share by Region (2020-2025)
Figure 100. North America NGS-based RNA-seq Production (K Units) Growth Rate (2020-2025)
Figure 101. Europe NGS-based RNA-seq Production (K Units) Growth Rate (2020-2025)
Figure 102. Japan NGS-based RNA-seq Production (K Units) Growth Rate (2020-2025)
Figure 103. China NGS-based RNA-seq Production (K Units) Growth Rate (2020-2025)
Figure 104. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 105. Global NGS-based RNA-seq Market Size by Type (M USD)
Figure 106. Sales Market Share of NGS-based RNA-seq by Type (2020-2033)
Figure 107. Sales Market Share of NGS-based RNA-seq by Type in 2024
Figure 108. Market Size Share of NGS-based RNA-seq by Type (2020-2033)
Figure 109. Market Size Share of NGS-based RNA-seq by Type in 2024
Figure 110. Global NGS-based RNA-seq Price (USD/Unit) by Type (2020-2033)
Figure 111. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 112. Global NGS-based RNA-seq Market Size by Application(M USD)
Figure 113. Global NGS-based RNA-seq Market Share by Application
Figure 114. Global NGS-based RNA-seq Sales Market Share by Application (2020-2033)
Figure 115. Global NGS-based RNA-seq Sales Market Share by Application in 2024
Figure 116. Global NGS-based RNA-seq Market Share by Application (2020-2033)
Figure 117. Global NGS-based RNA-seq Market Share by Application in 2024
Figure 118. Global NGS-based RNA-seq Sales Growth Rate by Application (2020-2033)